Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Valsartan plus amlodipine after inadequate response to amlodipine or felodipine monotherapy in hypertension
2006-001484-39Phase 3Completed
- Sponsor
- Novartis
- Start
- May 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of valsartan, amlodipine and felodipine in essential hypertension (2 arms), sponsored by Novartis. Primary endpoint: Primary efficacy endpoint. Started May 2006; status: completed.
02
Drugs
valsartanamlodipinefelodipine
03
Conditions
essential hypertension
Beyond the preview
Go deeper on 2006-001484-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-001484-39.